✦ LIBER ✦

Administration of anti-HER2 antibody after nonmyeloablative allogeneic stem cell transplantation in metastatic breast cancer

✍ Scribed by Banna, G L; Aversa, S M L; Crivellari, G; Ghiotto, C; Chiarion-Sileni, V; Monfardini, S

Book ID: 109998813
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 90 KB
Volume: 94
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6603114

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of the anti-idiotype antibody vaccin

Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer

✍ Phillips, G L; Reece, D E; Foon, K A; Bhattacharya-Chatterjee, M; Hale, G A; How 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

Soluble HER-2/neu neutralizes biologic e

Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro

✍ Thomas Brodowicz; Christoph Wiltschke; Alexandra C. Budinsky; Michael Krainer; G 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 58 KB 👁 1 views

Dose escalation and pharmacokinetic stud

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

✍ Tokuda, Y; Watanabe, T; Omuro, Y; Ando, M; Katsumata, N; Okumura, A; Ohta, M; Fu 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 331 KB

Targeting endothelin A receptor enhances

Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells

✍ Jeanett Fischgräbe; Martin Götte; Katharina Michels; Ludwig Kiesel; Pia Wülfing 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 600 KB

Human epidermal growth factor receptor 2 (HER2) is frequently overexpressed in human breast cancers. It is known to drive tumor growth and progression and represents a prominent target in breast cancer therapy. The endothelin (ET) system, in particular ET-1 and its receptor ET A R, is of major relev

Expression of C-erbB-2/HER-2 in patients

Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support

✍ Bewick, M; Chadderton, T; Conlon, M; Lafrenie, R; Morris, D; Stewart, D; Glück, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB